Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – Breast cancer patients found to have micrometastases in the sentinel lymph node (SLN) but who do not undergo completion axillary lymph node dissection…
NEW YORK (Reuters Health) – In the treatment of nodular goiter, the effect of radioiodine (I-131) therapy is potentiated by neoadjuvant administration of recombinant human thyroid stimulating hormone…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
NEW YORK (Reuters Health) – In selected patients with upper tract urothelial carcinoma, endoscopic management offers a nephron-sparing alternative to nephroureterectomy, researchers report in the June issue of…
NEW YORK (Reuters Health) – For distinguishing epithelial ovarian cancer from a benign mass, an algorithm that uses HE4 and CA125 is more sensitive and objective than the…
Actinic Keratoses (AKs) are precancerous growths on the skin, typically characterized by rough and dry skin lesions. In this video, Gary Goldenberg, MD, Assistant Professor of Dermatology and…
Protein energy malnutrition can cause death in post-operative and cancer patients. New protein-rich snacks can help remedy that situation, and offer a new solution for cancer patients undergoing…
NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – Up to 20% of tests for estrogen and progesterone receptors in breast cancers are false negatives or false positives, according to a consensus…
NEW YORK (Reuters Health) – Physicians should monitor serum testosterone levels during androgen-deprivation therapy (ADT) in men with prostate cancer, according to an April 16th online report in…
